Princess Máxima Center, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Lundlaan 6, 3584 EA Utrecht, the Netherlands.
Princess Máxima Center, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Laboratory of Behavioral Gastronomy, Centre for Healthy Eating and Food Innovation, Nassaustraat 36, 5911 BV, Venlo, the Netherlands.
Clin Nutr. 2024 Aug;43(8):1798-1811. doi: 10.1016/j.clnu.2024.05.028. Epub 2024 May 27.
BACKGROUND & AIMS: A dysfunctional hypothalamus may result in decreased feelings of satiety (hyperphagia), decreased energy expenditure, and increased fat storage as a consequence of hyperinsulinemia. Hypothalamic dysfunction may thus lead to morbid obesity and can be encountered in childhood as a consequence of congenital, genetic, or acquired disorders. There is currently no effective treatment for hypothalamic obesity (HO). However, comparable to alimentary obesity, dietary and lifestyle interventions may be considered the cornerstones of obesity treatment. We questioned the effect of dietary or lifestyle interventions for HO and systematically searched the literature for evidence on feasibility, safety, or efficacy of dietary or lifestyle interventions for childhood hypothalamic overweight or obesity.
A systematic search was conducted in MEDLINE (including Cochrane Library), EMBASE, and CINAHL (May 2023). Studies assessing feasibility, safety, or efficacy of any dietary or lifestyle intervention in children with hypothalamic overweight or obesity, were included. Animal studies, studies on non-diet interventions, and studies with no full text available were excluded. Because the number of studies to be included was low, the search was repeated for adults with hypothalamic overweight or obesity. Risk of bias was assessed with an adapted Cochrane Risk of Bias Tool. Level of evidence was assessed using the GRADE system. Descriptive data were described, as pooled-data analysis was not possible due to heterogeneity of included studies.
In total, twelve studies were included, with a total number of 118 patients (age 1-19 years) of whom one with craniopharyngioma, one with ROHHAD-NET syndrome, 50 with monogenic obesity, and 66 with Prader-Willi syndrome (PWS). Four studies reported a dietary intervention as feasible. However, parents did experience difficulties with children still stealing food, and especially lowering carbohydrates was considered to be challenging. Seven studies reported on efficacy of a dietary intervention: a well-balanced restrictive caloric diet (30% fat, 45% carbohydrates, and 25% protein) and various hypocaloric diets (8-10 kcal/cm/day) were considered effective in terms of weight stabilization or decrease. No negative effect on linear growth was reported. Four studies reported on specific lifestyle interventions, of which three also included a dietary intervention. Combined dietary and lifestyle intervention resulted in decreased BMI, although BMI returned to baseline values on long-term. One additional study was identified in adults after brain trauma and showed a significant reduction in BMI in one out of eight patients after a combined dietary and lifestyle intervention.
Hypocaloric diet or restrictive macronutrient diet with lower percentage of carbohydrates seems feasible and effective for childhood HO, although most of the studies had a high risk of bias, small cohorts without control groups, and were conducted in children with PWS only, compromising the generalizability. Lifestyle interventions only resulted in BMI decrease in short-term, indicating that additional guidance is needed to sustain its effect in the long-term. Literature on feasibility and efficacy of a dietary or lifestyle intervention for hypothalamic overweight or obesity is scarce, especially in children with acquired HO (following treatment for a suprasellar tumor). There is need for prospective (controlled) studies to determine which dietary and lifestyle intervention are most helpful for this specific patient group.
下丘脑功能障碍可能导致饱腹感降低(多食)、能量消耗减少和脂肪储存增加,其原因是胰岛素水平升高。因此,下丘脑功能障碍可能导致病态肥胖,并可能因先天性、遗传性或获得性疾病而在儿童期出现。目前,针对下丘脑性肥胖(HO)尚无有效的治疗方法。然而,与摄食性肥胖类似,饮食和生活方式干预可以被视为肥胖治疗的基石。我们探讨了饮食或生活方式干预对 HO 的影响,并系统地检索了文献,以评估饮食或生活方式干预对儿童下丘脑性超重或肥胖的可行性、安全性或疗效的证据。
在 MEDLINE(包括 Cochrane 图书馆)、EMBASE 和 CINAHL 中进行了系统检索(2023 年 5 月)。纳入评估任何饮食或生活方式干预对下丘脑性超重或肥胖儿童的可行性、安全性或疗效的研究。排除动物研究、非饮食干预研究以及无法获取全文的研究。由于纳入的研究数量较少,因此针对下丘脑性超重或肥胖的成年人重复了该检索。使用经过改编的 Cochrane 偏倚风险工具评估偏倚风险。使用 GRADE 系统评估证据水平。由于纳入研究的异质性,无法进行汇总数据分析,因此仅描述了描述性数据。
共纳入了 12 项研究,总计纳入了 118 名患者(年龄 1-19 岁),其中 1 名患者患有颅咽管瘤,1 名患者患有 ROHHAD-NET 综合征,50 名患者患有单基因肥胖症,66 名患者患有 Prader-Willi 综合征(PWS)。4 项研究报告了饮食干预的可行性。然而,父母确实发现孩子们仍然存在偷食的问题,尤其是降低碳水化合物的摄入被认为具有挑战性。7 项研究报告了饮食干预的疗效:均衡的限制热量饮食(30%脂肪、45%碳水化合物和 25%蛋白质)和各种低热量饮食(8-10 kcal/cm/天)被认为在稳定或降低体重方面有效。未报告对线性生长有不良影响。4 项研究报告了特定的生活方式干预,其中 3 项还包括饮食干预。联合饮食和生活方式干预导致 BMI 降低,尽管在长期随访中 BMI 恢复到基线值。在成人中还确定了一项针对脑外伤的额外研究,显示在接受联合饮食和生活方式干预的 8 名患者中,有 1 名患者的 BMI 显著降低。
低热量饮食或限制宏量营养素的饮食,碳水化合物比例较低,对于儿童下丘脑性肥胖似乎是可行且有效的,尽管大多数研究存在较高的偏倚风险、没有对照组的小样本队列以及仅在 PWS 儿童中进行,限制了其推广性。生活方式干预仅在短期导致 BMI 降低,表明需要额外的指导来维持其长期效果。针对下丘脑性超重或肥胖的饮食或生活方式干预的可行性和疗效的文献很少,尤其是在因治疗鞍上肿瘤而获得性下丘脑肥胖的儿童中。需要前瞻性(对照)研究来确定哪种饮食和生活方式干预对这一特定患者群体最有帮助。